Kathleen Dorritie
0000-0002-0863-8573
University of Pittsburgh
5 papers found
Refreshing results…
Overall survival of patients with cHL who progress after autologous stem cell transplant: results in the novel agent era
Patient-reported outcomes in ZUMA-7, a phase 3 study of axicabtagene ciloleucel in second-line large B-cell lymphoma
Phase 1 TRANSCEND CLL 004 study of lisocabtagene maraleucel in patients with relapsed/refractory CLL or SLL
Selective Inhibition of the Second Bromodomain of BET Family Proteins Results in Robust Antitumor Activity in Preclinical Models of Acute Myeloid Leukemia
Outcomes of Patients with Large B-cell Lymphoma Progressing after Axicabtagene Ciloleucel
Missing publications? Search for publications with a matching author name.